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Campylobacters are the one of the most common causes of bacterial gastroenteritis in humans (2) . 44
Though usually a mild and self-limiting disease, antimicrobial therapy is needed in severe and 45 prolonged cases, in immunocompromised patients and in pregnant women as well as in very young and 46 very old patients (2). Currently, macrolides and fluoroquinolones are considered to be the first-and 47 second-choice alternatives for the antimicrobial treatment of campylobacteriosis. In recent years, 48 however, resistance against both of these antimicrobial groups has complicated the empirical treatment 49 of bacterial gastroenteritis (1). Therefore, reliable routine susceptibility testing is required to provide an 50 adequate antimicrobial treatment for severely ill patients with campylobacteriosis. Moreover, correct 51 measures are needed to monitor the Campylobacter resistance situation worldwide 52 Several laboratory methods have been applied for the susceptibility testing of Campylobacter 53 species. The agar dilution and broth dilution methods have been standardized by the Clinical and 54
Laboratory Standards Insitute (3, 4, 5, 6) . The E-test is also an MIC-based method which has been 55 widely used, although not standardized. The disk diffusion method has been standardized by the CLSI, 56 but according to those standards, it should only be used as a screening method for resistance to 57 erythromycin and ciprofloxacin: disk diffusion zone of 6 mm (growth up to the edge of a 6-mm disk) 58 indicates resistance, while any inhibition zone would require an MIC determination of susceptibility 59 (4). 60
A number of previous studies have compared the disk diffusion method with the other 61 susceptibility testing methods of Campylobacter spp. In some of those studies, the results have been in 62 line, though in some other studies, inconsistencies between the methods have been observed (8, 9, 15, 63 17-20 The agar dilution and the E-test method. The MICs of the Campylobacter strains were 87 determined by the standard agar plate dilution method for six antimicrobials (3, 12). The 90mm plates 88 were incubated in a microaerobic atmosphere (CampyPak, BBL) at 35 + 1 °C for 48 h. The MIC 89 determinations were done twice for each strain. The antimicrobial agents evaluated were clindamycin, 90 erythromycin, nalidixic acid, tetracycline, Sigma (Steinheim, Germany); azithromycin and 91 ciprofloxacin, Fluka (Buchs, Switzerland). The MICs of the isolates to tigecycline were determined by 92 the Etest, Biodisk AB (Solna, Sweden) as described previously (14) . 93
The disk diffusion method. The following antimicrobial disks were used: clindamycin 2 µg, 
Results
117
Determined by the agar dilution method, a total of 33 Campylobacter strains were erythromycin-118 resistant (MIC ≥ 16 µg/ml) and 141 strains were -susceptible (MIC < 16 µg/ml) ( Table 1) . A total of 87 119 strains were ciprofloxacin-resistant (MIC ≥ 4 µg/ml) and 87 strains were -susceptible (MIC < 4 µg/ml). 120
Determined by the E-test, all 174 strains were susceptible to tigecycline. The MIC determinations were 121 made twice for each strain obtaining identical susceptibility results. 122
For the erythromycin-resistant strains, the total number of the measurements for the erythromycin 123 disk was 129. Of the 33 erythromycin-resistant strains, 24 (73%) showed an erythromycin inhibition 124 zone of 6 mm (i.e. no inhibition zone) in all repeated measurements (total number 115). Seven (21%) 125 erythromycin-resistant strains with the MICs ≥ 128 µg/ml showed inhibition zones between 6 and 44 126 mm; two (6.1%) of erythromycin-resistant strains with the MICs of 16 and 64 µg/ml, respectively, 127 showed inhibition zones between 22 and 42 mm in all repeated measurements. For the 141 128 erythromycin-susceptible isolates, a total of 477 measurements were performed. For these susceptible 129 strains, the inhibition zones for erythromycin varied from 6 to 61 mm. Ten (2.1%) measurements were 130 equal to or less than 20 mm, and two (0.42%) were 6 mm. 131
For the ciprofloxacin-resistant strains, the total number of the measurements for the ciprofloxacin 132 disk was 312. Of the 87 ciprofloxacin-resistant strains, 47 (54%) showed a ciprofloxacin inhibition 133 zone of 6 mm in all repeated measurements (total number 231), while for 40 (46%) strains, the 134 inhibition zone varied from 6 to 60 mm. In 11 (12%) measurements, the inhibition zone was over 10 135 mm. For six ciprofloxacin-resistant strains with the MICs between 4 and 32 µg/ml, the inhibition zones 136 were equal to or over 20 mm in all repeated measurements. For the 87 ciprofloxacin-susceptible 137 isolates, a total of 267 measurements were performed. For these susceptible strains, the inhibition zones 138
for ciprofloxacin varied between 6 and 66 mm. A 6-mm inhibition zone was observed in nine Table 1 . 141
For all measurements of azithromycin, ciprofloxacin, clindamycin, erythromycin, nalidixic acid, 142 and tetracycline, coefficient of variation (CV) was determined for the resistant and susceptible strains 143 (Figure 1, Table 1 ). For all compounds, strains were found with a substantial variation between the 144 repetitions of the disk diffusion test. For the erythromycin disk diffusion tests, the CV variation was 145 less than 5% for 53 strains and greater than or equal to 15% for 36 strains. For ciprofloxacin, the 146 variation was small for 64 strains and substantial for 52 strains. Seventeen strains showed a substantial 147 variation for both erythromycin and ciprofloxacin. For all of the strains susceptible to these 148 antimicrobial agents, the mean of maximum difference between two different measurements was over 8 149 mm (Table 1) . Even for the resistant strains, the mean values of maximum difference over 4 mm were 150 found for ciprofloxacin, nalidixic acid and tetracycline. The mean values of coefficient of variation for 151 all antimicrobial agents were over 10%. When the different repetition times were evaluated, significant 152 differences were observed for all antimicrobial agents and for all strains except for the macrolide-153 resistant strains regarding erythromycin and azithromycin (Table 1) should only be used as a screening method for resistance to erythromycin and ciprofloxacin in 179
Campylobacter spp., and that any inhibition zone around the disk demands an MIC-based 180 determination of susceptibility (3, 4, 5, 6, 13) . 181
These results indicate that there is a need for a standardized protocol for susceptibility testing in 182 clinical microbiology laboratories, as well as determining clear resistance breakpoints and interpretive 183 criteria for Campylobacter spp. The falsely diagnosed resistant strains may lead to an excessive use of 184 more toxic and possibly even less effective antimicrobial treatment for patients with 185 campylobacteriosis (19). The most serious threat is that resistant strains falsely diagnosed as 186 susceptible may lead to ineffective antimicrobial treatment even in invasive and life threatening 187 infections. Infections with resistant strains have been reported in association with a five-fold increase 188 of the risk of invasive illness or death (7). Especially for that reason, it is of importance to be able to 189 correctly distinguish the resistant strains. Moreover, an adequate worldwide monitoring of 190
Campylobacter resistance is impossible, if the resistance rates are falsely reported due to unreliable 191 susceptibility testing. 192
Several previous papers have focused on the efficacy and accuracy of the disk diffusion method 193
and the E-test method when compared to the agar plate dilution or broth microdilution methods, with 194 somewhat contradictory results (8, 9, 15, 17, 19, 20) . In these studies, the disk diffusion tests were 195 performed only once for each strain. Gaudreau et al. (8, 9) have found the disk diffusion method to be a 196 reliable, easy and inexpensive method for the testing of the susceptibility of C. jejuni to erythromycin, 197 ciprofloxacin, and tetracycline. Corroborating the present study, the results of e.g., van der Beek et al. 198 are different (19) . They reinvestigated 48 erythromycin-resistant C. jejuni and C. coli strains 199 retrospectively to re-evaluate erythromycin resistance, and only 11-14% of the C. jejuni strains and 200 67% of the C. coli strains were erythromycin-resistant in the second analysis. In that study, the initial 201 possibility that differences could also be caused by instability of the erythromycin resistance. In the 210 present study, no rising trend during the repetitions was observed in the inhibition zone variation 211 between the different measurement times. Therefore, the instability of the erythromycin resistance does 212 not seem to be the factor underlying the variation in our strains. 213
In conclusion, our results show that the disk diffusion method may not be a reliable tool for 214 susceptibility testing of Campylobacter spp. This is a major concern due to the wide use of the disk 215 diffusion method in routine clinical laboratories as well as in some research laboratories. Accurate 216 determination of Campylobacter susceptibility and resistance is of vital importance to assure an 217 adequate antimicrobial therapy for patients with severe forms of the disease and, also, to efficiently 218 monitor the antimicrobial resistance situation of Campylobacter spp. worldwide. Further studies are 219 needed to assess whether the disk diffusion test method could be improved or whether all 220 susceptibilities of campylobacters should be done using an MIC-based method. 
